SCHEMBL4811284

SCHEMBL4811284

C=CCc1cc(C(=O)CCc2nc(-c3ccc(Cl)cc3Cl)oc2C(C)C)ccc1OC(C)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 4/20 0.45
PPARA Q07869 4/20 0.45
PPARD Q03181 3/20 0.45
ALOX5 P09917 2/20 0.37
KDM4E B2RXH2 3/20 0.35
MAPT P10636 3/20 0.35
ELANE P08246 1/20 0.35
PTGDR Q13258 1/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.34
HSD17B10 Q99714 2/20 0.34
NPC1 O15118 1/20 0.34
POLB P06746 1/20 0.34
TSHR P16473 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
SRD5A1 P18405 1/20 0.33
ADRB2 P07550 1/20 0.33
MRGPRX4 Q96LA9 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2466958 0.91 PPARG (0.44) PPARGPPARAPPARDKDM4EMAPT
SCHEMBL2466956 0.91 PPARG (0.43) PPARGPPARAPPARDKDM4EMAPT
SCHEMBL12732395 0.91 PPARG (0.49) PPARGPPARAPPARDKDM4EMAPT
SCHEMBL24658331 0.89 PPARG (0.46) PPARGPPARAPPARDKDM4EMAPT
SCHEMBL2467711 0.89 PPARG (0.56) PPARGPPARAPPARDKDM4EMAPT
SCHEMBL30003957 0.89 PPARG (0.46) PPARGPPARAPPARDKDM4EMAPT
SCHEMBL4754218 0.89 PPARA (0.49) PPARGPPARAPPARDKDM4EMAPT
SCHEMBL2469821 0.88 PPARG (0.44) PPARGPPARAPPARDKDM4EMAPT
SCHEMBL4752344 0.88 PPARA (0.55) PPARGPPARAPPARDKDM4EMAPT
SCHEMBL4754216 0.82 PPARA (0.48) PPARGPPARAPPARDKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2464349-A2 USE OF PPAR DELTA LIGANDS FOR THE TREATMENT OR PREVENTION OF INFLAMMATION OR ENERGY METABOLISM/PRODUCTION RELATED DISEASES Cerenis Therapeutics S.A. (FR) 2012-06-20 EP disclosed
WO-2011020001-A2 USE OF PPAR DELTA LIGANDS FOR THE TREATMENT OR PREVENTION OF INFLAMMATION OR ENERGY METABOLISM/PRODUCTION RELATED DISEASES CERENIS THERAPEUTICS S.A. (FR) 2011-02-17 WO disclosed
WO-2008154023-A1 NOVEL USES OF PPAR DELTA AGONISTS CERENIS THERAPEUTICS S.A. (FR) 2008-12-18 WO disclosed